Chengyu Jiang
University of California, Riverside(US)University of Science and Technology of China(CN)Chinese University of Hong Kong(HK)Chinese Academy of Sciences(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Wenzhou Medical University(CN)Center for NanoScience(DE)Zhejiang Ocean University(CN)Affiliated Eye Hospital of Wenzhou Medical College(CN)Guangzhou Institute of Energy Conversion(CN)National Center for Nanoscience and Technology(CN)University of Chinese Academy of Sciences(CN)Shandong University of Science and Technology(CN)
Publications by Year
Research Areas
Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Advanced MEMS and NEMS Technologies, Surface Modification and Superhydrophobicity
Most-Cited Works
- → A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury(2005)3,627 cited
- → PPAR-γ agonists inhibit production of monocyte inflammatory cytokines(1998)2,889 cited
- → Angiotensin-converting enzyme 2 protects from severe acute lung failure(2005)2,546 cited
- → Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes(2016)2,150 cited
- → Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury(2020)2,148 cited
- → Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury(2008)1,345 cited